These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1828681)

  • 1. Topical PUVA therapy for vitiligo.
    Halder RM
    Dermatol Nurs; 1991 Jun; 3(3):178-80, 198. PubMed ID: 1828681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy (PUVA) in psoriasis and vitiligo.
    Shenoi SD; Prabhu S;
    Indian J Dermatol Venereol Leprol; 2014; 80(6):497-504. PubMed ID: 25382505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
    Hegyi V; Petrovajová M; Novotný M
    Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUVA therapy.
    Helm TN; Dijkstra JW; Ferrara RJ; Glanz S
    Am Fam Physician; 1991 Mar; 43(3):908-12. PubMed ID: 2000735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PUVA therapy on electrodermal activity parameters in vitiligo patients.
    Dolu N; Ferahbaş A; Ozesmi C; Peker D; Açik C
    Auton Neurosci; 2005 Mar; 118(1-2):102-7. PubMed ID: 15795183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photo(chemo)therapy for vitiligo.
    Pacifico A; Leone G
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood vitiligo successfully treated with bath PUVA.
    Mai DW; Omohundro C; Dijkstra JW; Bailin PL
    Pediatr Dermatol; 1998; 15(1):53-5. PubMed ID: 9496807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study.
    Singh S; Khandpur S; Sharma VK; Ramam M
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1344-51. PubMed ID: 23066663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
    Adişen E; Karaca F; Oztaş M; Gürer MA
    Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
    [No Abstract]   [Full Text] [Related]  

  • 14. Outdoor and office photochemotherapy of vitiligo: a comparison.
    Wennersten G; Hägermark O
    Photodermatol; 1984 Apr; 1(2):91-3. PubMed ID: 6531288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we treat vitiligo.
    Kenney JA; Grimes PE
    Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
    Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
    J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome.
    Parsad D; Pandhi R; Dogra S; Kanwar AJ; Kumar B
    Br J Dermatol; 2003 Feb; 148(2):373-4. PubMed ID: 12588405
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo: care and treatment.
    Moore SM; Lambert V
    Dermatol Nurs; 1991 Feb; 3(1):15-20. PubMed ID: 1825277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.